Phase II Trial

Imatinib is active in glioblastoma multiforme expressing platelet-derived growth factor receptor Imatinibe é ativo no glioblastoma multiforme com expressão do receptor do fator de crescimento derivado de plaquetas

Astrocyte / Adverse Event / Glioblastoma Multiforme / Drug Therapy / Brain Neoplasm / Therapeutic Use / Phase II Trial / Therapeutic Use / Phase II Trial

Imatinibe é ativo no glioblastoma multiforme com expressão do receptor do fator de crescimento derivado de plaquetas Imatinib is active in glioblastoma multiforme expressing platelet-derived growth factor receptor

Astrocyte / Adverse Event / Glioblastoma Multiforme / Drug Therapy / Brain Neoplasm / Therapeutic Use / Phase II Trial / Therapeutic Use / Phase II Trial

Temozolomide as salvage treatment in primary brain lymphomas

British / Apoptosis / Primary / Nature / Cell Division / Adipose tissue / Lymphoma / Humans / Female / Male / Aged / Middle Aged / Adult / Cancer cells / Cancers / Brain Neoplasms / Confidence Interval / Phase II Trial / Adipose tissue / Lymphoma / Humans / Female / Male / Aged / Middle Aged / Adult / Cancer cells / Cancers / Brain Neoplasms / Confidence Interval / Phase II Trial

Temozolomide as salvage treatment in primary brain lymphomas

British / Apoptosis / Primary / Nature / Cell Division / Adipose tissue / Lymphoma / Humans / Female / Male / Aged / Middle Aged / Adult / Cancer cells / Cancers / Brain Neoplasms / Confidence Interval / Phase II Trial / Adipose tissue / Lymphoma / Humans / Female / Male / Aged / Middle Aged / Adult / Cancer cells / Cancers / Brain Neoplasms / Confidence Interval / Phase II Trial

Imatinib is active in glioblastoma multiforme expressing platelet-derived growth factor receptor Imatinibe é ativo no glioblastoma multiforme com expressão do receptor do fator de crescimento derivado de plaquetas

Astrocyte / Adverse Event / Glioblastoma Multiforme / Drug Therapy / Brain Neoplasm / Therapeutic Use / Phase II Trial / Therapeutic Use / Phase II Trial

Imatinibe é ativo no glioblastoma multiforme com expressão do receptor do fator de crescimento derivado de plaquetas Imatinib is active in glioblastoma multiforme expressing platelet-derived growth factor receptor

Astrocyte / Adverse Event / Glioblastoma Multiforme / Drug Therapy / Brain Neoplasm / Therapeutic Use / Phase II Trial / Therapeutic Use / Phase II Trial

Temozolomide as salvage treatment in primary brain lymphomas

British / Apoptosis / Primary / Nature / Cell Division / Adipose tissue / Lymphoma / Humans / Female / Male / Aged / Middle Aged / Adult / Cancer cells / Cancers / Brain Neoplasms / Confidence Interval / Phase II Trial / Adipose tissue / Lymphoma / Humans / Female / Male / Aged / Middle Aged / Adult / Cancer cells / Cancers / Brain Neoplasms / Confidence Interval / Phase II Trial

Temozolomide as salvage treatment in primary brain lymphomas

British / Apoptosis / Primary / Nature / Cell Division / Adipose tissue / Lymphoma / Humans / Female / Male / Aged / Middle Aged / Adult / Cancer cells / Cancers / Brain Neoplasms / Confidence Interval / Phase II Trial / Adipose tissue / Lymphoma / Humans / Female / Male / Aged / Middle Aged / Adult / Cancer cells / Cancers / Brain Neoplasms / Confidence Interval / Phase II Trial

Copyright © 2017 DADOSPDF Inc.